TT virus of certain genotypes may reduce the platelet count in patients who achieve a sustained virologic response to interferon treatment for chronic hepatitis C
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-06-01
著者
-
OKAMOTO Hiroaki
Immunology Division and Division of Molecular Virology, Jichi Medical School
-
Kojima H
Department Of Gastroenterology National Tokyo Hospital
-
YAGURA Michiyasu
Department of Gastroenterology, National Hospital Organization Tokyo Hospital
-
TOKITA Hajime
Department of Gastroenterology, National Hospital Organization Tokyo Hospital
-
KAMITSUKASA Hiroshi
Department of Gastroenterology, National Hospital Organization Tokyo Hospital
-
HARADA Hideharu
Department of Gastroenterology, National Hospital Organization Tokyo Hospital
-
MURAI Seiyou
Department of Gastroenterology, National Tokyo Hospital
-
TAKAHASHI Masaharu
Immunology Division and Division of Molecular Virology, Jichi Medical School
-
Okamoto Hiroaki
Immunology Division And Division Of Molecular Virology Jichi Medical School
-
Yagura Michiyasu
Department Of Gastroenterology National Tokyo Hospital
-
Murai Seiyou
Department Of Gastroenterology National Tokyo Hospital
-
Tokita Hajime
Department Of Gastroenterology National Tokyo Hospital
-
Takahashi Masaharu
Immunology Division And Division Of Molecular Virology Jichi Medical School
-
Harada Hideharu
Department Of Gastroenterology National Tokyo Hospital
関連論文
- Re-evaluation of the Serum Alanine Aminotransferase Upper Normal Limit in Chronic Hepatitis C Patients
- TT virus infection in cases of fulminant hepatic failure-evaluation by clonality based on amino acid sequence of hypervariable regions
- Factors regarding increase of platelet counts in chronic hepatitis C patients with sustained virological response to interferon : Relation to serum thrombopoietin levels
- Circulating KL-6 level at baseline is a predictive indicator for the occurrence of interstitial pneumonia during interferon treatment for chronic hepatitis C
- TT virus of certain genotypes may reduce the platelet count in patients who achieve a sustained virologic response to interferon treatment for chronic hepatitis C
- Influence of TT virus infection on the thrombocytopenia of patients with chronic liver disease
- Influence of TT virus on the histopathological features of nonalcoholic fatty liver disease
- Influence of TT virus on the clinical course of alcoholic liver disease
- Does the control of alanine aminotransferase levels lead to a regression of liver fibrosis in chronic hepatitis C patients?
- Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-α therapy: including quantitative assessment by a morphometric method
- Parameters predicting response to ursodeoxycholic acid therapy in chronic hepatitis C
- TT virus : virological and genomic characteristics and disease associations
- Helicobacter pylori and TT virus prevalence in Japanese children
- Clinical evaluation of chronic liver diseases induced by different hepatitis C virus genotype in Japan, focused on the difference between genotypes III/2a and IV/2b
- Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology^1
- Differential effect of cytotoxic T lymphocyte variant epitopes on generation and cytotoxicity in chronic hepatitis C virus infection
- The prevalence of GB virus C, risk factors and its relationship with other hepatitis viruses in a general population in Jakarta, Indonesia
- Cold activation of complement enhancing with the duration of storage in sera from blood donors with hepatitis C virus RNA
- HLA B44-restricted cytotoxic T lymphocyte responses to the peptides of HCV nucleprotein residues 81-100 in patients with chronic hepatitis C
- IgM-class antibodies to TT virus (TTV) in patients with acute TTV infection
- A unique set of mutations in the 'preX' region of hepatitis B virus DNA frequently foun in patients but not in asymptomatic carriers: implication for a novel variant
- Hepatitis C virus genotypes and co-infection with GB virus C in patients with anti-HCV-positive chronic liver disease in Jakarta, Indonesia
- Genotypes of GB virus C and hepatitis C virus in hepatitis patients in India, Iran and Slovenia
- Efficacy of hepatitis B vaccines with and without preS2-region product in Sumo wrestlers in Japan
- Molecular and clinical characteristics of the hepatitis C virus genotype '2c' found in Italians in Italy and France
- Infection with GB virus C in the patients with primary hepatocellular carcinoma in Japan
- Prevalence of Anti-Hepatitis C antibodies in a Rural Community without High Mortality from Liver Disease in Niigata Prefecture
- Persistence of hepatitis B viremia after recovery from acute hepatitis B : correlation between anti-HBc titer and HBV DNA in serum
- Treatment of chronic hepatitis C patients with amantadine
- Rebound of hepatitis C virus RNA in serum after withdrawal of interferon in patients with advanced liver disease
- Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis